These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28694765)

  • 1. Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides.
    Zakeri-Milani P; Mussa Farkhani S; Shirani A; Mohammadi S; Shahbazi Mojarrad J; Akbari J; Valizadeh H
    EXCLI J; 2017; 16():650-662. PubMed ID: 28694765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.
    Mohammadi S; Zakeri-Milani P; Golkar N; Farkhani SM; Shirani A; Shahbazi Mojarrad J; Nokhodchi A; Valizadeh H
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1572-1585. PubMed ID: 28933182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.
    Soleymani-Goloujeh M; Nokhodchi A; Niazi M; Najafi-Hajivar S; Shahbazi-Mojarrad J; Zarghami N; Zakeri-Milani P; Mohammadi A; Karimi M; Valizadeh H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):91-103. PubMed ID: 29258339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery.
    Zakeri-Milani P; Najafi-Hajivar S; Sarfraz M; Nokhodchi A; Mohammadi H; Montazersaheb S; Niazi M; Hemmatzadeh M; Soleymani-Goloujeh M; Baradaran B; Shahbazi Mojarrad J; Farshbaf M; Gholikhani T; Valizadeh H
    Iran J Pharm Res; 2021; 20(3):506-515. PubMed ID: 34904004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
    Kardani K; Milani A; H Shabani S; Bolhassani A
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates.
    Mohammadi S; Shahbazi Mojarrad J; Zakeri-Milani P; Shirani A; Mussa Farkhani S; Samadi N; Valizadeh H
    Adv Pharm Bull; 2015 Mar; 5(1):41-9. PubMed ID: 25789218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin
    Li Z; Wang X; Teng D; Mao R; Hao Y; Yang N; Chen H; Wang X; Wang J
    Eur J Med Chem; 2018 Feb; 145():263-272. PubMed ID: 29329001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Peptide delivery into cells by using the synergistic effects of a cell-penetrating Peptide and a chemical drug to alter cell permeability.
    Ma JL; Wang H; Wang YL; Luo YH; Liu CB
    Mol Pharm; 2015 Jun; 12(6):2040-8. PubMed ID: 25886885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the research and application of cell penetrating peptides].
    Xie Y; Wang S; Yuan Q; Xie N
    Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1162-1173. PubMed ID: 31328473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides.
    Maiolo JR; Ferrer M; Ottinger EA
    Biochim Biophys Acta; 2005 Jun; 1712(2):161-72. PubMed ID: 15935328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
    ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents.
    Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade.
    Shoari A; Tooyserkani R; Tahmasebi M; Löwik DWPM
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
    Futaki S; Nakase I
    Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
    Xiang Y; Shan W; Huang Y
    Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.